Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Evaluation of the brain-specific delivery of radioiodinated (iodophenyl)alkyl-substituted amines coupled to a dihydropyridine carrier

Journal Article · · J. Med. Chem.; (United States)
DOI:https://doi.org/10.1021/jm00149a006· OSTI ID:5721893
To evaluate the potential usefulness of radioiodinated phenylamines attached to dihydropyridine carriers as a means of brain-specific delivery of radiopharmaceuticals, 1-methyl-3-(N-(beta- (4-(125I)iodophenyl)ethyl)carbamoyl)-1,4-dihydropyridine ((125I)-9) and 1-methyl-3-(N-(4-(125I)iodophenyl)carbamoyl)-1,4-dihydropyridine ((125I)-13) have been prepared by dithionite reduction of the corresponding pyridinium precursors, (125I)-8 and (125I)-12, respectively. Formation of 8 involved coupling of (p-aminophenyl)ethylamine with N-succinimidyl (1-methyl-3-pyridinio)formate iodide (4) followed by transformation to the corresponding N-piperidinyl- (6) or (diethylamino)- (7) triazines that were converted to 8 by treatment with HI. Alternatively, 12 was prepared by initial conversion of (4-amino-phenyl)mercuric acetate (10) to 4-iodoaniline (11) by treatment with I2 and then coupling with 4. The radioiodinated quaternary products, 8 and 12, showed low brain uptake and low brain to blood ratios, whereas the dihydropyridine analogues, 9 and 13, showed comparatively good brain uptake and good brain to blood ratios in rats. These data demonstrate that dihydropyridine-coupled radiopharmaceuticals can cross the blood-brain barrier and the technique may be useful for the measurement of cerebral blood perfusion.
OSTI ID:
5721893
Journal Information:
J. Med. Chem.; (United States), Journal Name: J. Med. Chem.; (United States) Vol. 11; ISSN JMCMA
Country of Publication:
United States
Language:
English